189 related articles for article (PubMed ID: 25129990)
1. Premature cardiac senescence in DahlS.Z-Lepr(fa)/Lepr(fa) rats as a new animal model of metabolic syndrome.
Takahashi K; Takatsu M; Hattori T; Murase T; Ohura S; Takeshita Y; Watanabe S; Murohara T; Nagata K
Nagoya J Med Sci; 2014 Feb; 76(1-2):35-49. PubMed ID: 25129990
[TBL] [Abstract][Full Text] [Related]
2. Cardiac remodeling and diastolic dysfunction in DahlS.Z-Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome.
Murase T; Hattori T; Ohtake M; Abe M; Amakusa Y; Takatsu M; Murohara T; Nagata K
Hypertens Res; 2012 Feb; 35(2):186-93. PubMed ID: 21918527
[TBL] [Abstract][Full Text] [Related]
3. Calorie restriction attenuates cardiac remodeling and diastolic dysfunction in a rat model of metabolic syndrome.
Takatsu M; Nakashima C; Takahashi K; Murase T; Hattori T; Ito H; Murohara T; Nagata K
Hypertension; 2013 Nov; 62(5):957-65. PubMed ID: 24041949
[TBL] [Abstract][Full Text] [Related]
4. Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z-Lepr(fa)/Lepr(fa) rats as a new animal model of metabolic syndrome.
Murase T; Hattori T; Ohtake M; Nakashima C; Takatsu M; Murohara T; Nagata K
Hypertension; 2012 Mar; 59(3):694-704. PubMed ID: 22275535
[TBL] [Abstract][Full Text] [Related]
5. Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.
Hattori T; Murase T; Takatsu M; Nagasawa K; Matsuura N; Watanabe S; Murohara T; Nagata K
J Am Heart Assoc; 2014 Dec; 3(6):e001312. PubMed ID: 25468654
[TBL] [Abstract][Full Text] [Related]
6. Restraint stress exacerbates cardiac and adipose tissue pathology via β-adrenergic signaling in rats with metabolic syndrome.
Matsuura N; Nagasawa K; Minagawa Y; Ito S; Sano Y; Yamada Y; Hattori T; Watanabe S; Murohara T; Nagata K
Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1275-86. PubMed ID: 25770247
[TBL] [Abstract][Full Text] [Related]
7. The prebiotic fiber inulin ameliorates cardiac, adipose tissue, and hepatic pathology, but exacerbates hypertriglyceridemia in rats with metabolic syndrome.
Komatsu Y; Aoyama K; Yoneda M; Ashikawa S; Nakano S; Kawai Y; Cui X; Furukawa N; Ikeda K; Nagata K
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H281-H295. PubMed ID: 33216624
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486.
Nagasawa K; Matsuura N; Takeshita Y; Ito S; Sano Y; Yamada Y; Uchinaka A; Murohara T; Nagata K
Nutr Diabetes; 2016 Apr; 6(4):e207. PubMed ID: 27110688
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat.
Hattori T; Murase T; Ohtake M; Inoue T; Tsukamoto H; Takatsu M; Kato Y; Hashimoto K; Murohara T; Nagata K
Nutr Diabetes; 2011 Jan; 1(1):e1. PubMed ID: 23154293
[TBL] [Abstract][Full Text] [Related]
10. Effects of pioglitazone on cardiac and adipose tissue pathology in rats with metabolic syndrome.
Matsuura N; Asano C; Nagasawa K; Ito S; Sano Y; Minagawa Y; Yamada Y; Hattori T; Watanabe S; Murohara T; Nagata K
Int J Cardiol; 2015 Jan; 179():360-9. PubMed ID: 25464487
[TBL] [Abstract][Full Text] [Related]
11. Surgical ablation of whitened interscapular brown fat ameliorates cardiac pathology in salt-loaded metabolic syndrome rats.
Komatsu Y; Aoyama K; Yoneda M; Ito S; Sano Y; Kawai Y; Cui X; Yamada Y; Furukawa N; Ikeda K; Nagata K
Ann N Y Acad Sci; 2021 May; 1492(1):11-26. PubMed ID: 33340110
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome.
Yamada Y; Takeuchi S; Yoneda M; Ito S; Sano Y; Nagasawa K; Matsuura N; Uchinaka A; Murohara T; Nagata K
Int J Cardiol; 2017 Aug; 240():332-338. PubMed ID: 28499669
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of salt-induced exacerbation of cardiac, renal, and visceral fat pathology in rats with metabolic syndrome by surgical removal of subcutaneous fat.
Aoyama K; Komatsu Y; Yoneda M; Nakano S; Ashikawa S; Kawai Y; Cui X; Ikeda K; Nagata K
Nutr Diabetes; 2020 Aug; 10(1):28. PubMed ID: 32778644
[TBL] [Abstract][Full Text] [Related]
14. Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.
Takeshita Y; Watanabe S; Hattori T; Nagasawa K; Matsuura N; Takahashi K; Murohara T; Nagata K
Hypertens Res; 2015 Nov; 38(11):741-50. PubMed ID: 26155752
[TBL] [Abstract][Full Text] [Related]
15. Highly purified eicosapentaenoic acid ameliorates cardiac injury and adipose tissue inflammation in a rat model of metabolic syndrome.
Ito S; Sano Y; Nagasawa K; Matsuura N; Yamada Y; Uchinaka A; Murohara T; Nagata K
Obes Sci Pract; 2016 Sep; 2(3):318-329. PubMed ID: 27708849
[TBL] [Abstract][Full Text] [Related]
16. Effects of mTOR inhibition on cardiac and adipose tissue pathology and glucose metabolism in rats with metabolic syndrome.
Uchinaka A; Yoneda M; Yamada Y; Murohara T; Nagata K
Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805979
[TBL] [Abstract][Full Text] [Related]
17. Roles of oxidative stress and the mineralocorticoid receptor in cardiac pathology in a rat model of metabolic syndrome.
Takahashi K; Murase T; Takatsu M; Matsuura N; Nagasawa K; Hattori T; Watanabe S; Murohara T; Nagata K
Nagoya J Med Sci; 2015 Feb; 77(1-2):275-89. PubMed ID: 25797993
[TBL] [Abstract][Full Text] [Related]
18. Effect of ipragliflozin, an SGLT2 inhibitor, on cardiac histopathological changes in a non-diabetic rat model of cardiomyopathy.
Takasu T; Takakura S
Life Sci; 2019 Aug; 230():19-27. PubMed ID: 31125563
[TBL] [Abstract][Full Text] [Related]
19. Generation of rat-induced pluripotent stem cells from a new model of metabolic syndrome.
Takenaka-Ninagawa N; Kawabata Y; Watanabe S; Nagata K; Torihashi S
PLoS One; 2014; 9(8):e104462. PubMed ID: 25111735
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
